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ABSTRACT
SchistoDB (http://schistoDB.net/) is a genomic
database for the parasitic organism Schistosoma
mansoni, one of the major causative agents of
schistosomiasis worldwide. It currently incorpo-
rates sequences and annotation for S. mansoni in
a single user-friendly database. Several genomic
scale analyses are available as well as ESTs, oligo-
nucleotides, metabolic pathways and drugs. In this
article, we describe the data sets and its analyses,
how to query the database and tools available in the
website.
INTRODUCTION
The ﬂatworm Schistosoma mansoni is one of the major
etiological agents of human intestinal schistosomiasis
mansoni. The disease aﬀects over 200 million individuals
in 74 developing countries and causes high morbidity in
infected populations (1). Current strategies of disease con-
trol depend heavily on the use of the sole drug available
for mass treatment, praziquantel (1). Treatment is eﬀective
in single dose and has resulted in decreased morbidity at
endemic areas. However, it is highly desirable that control
strategies include other countermeasures such as vaccines
and new drugs. In addition, Praziquantel is not eﬃcacious
against all life cycle forms present in the human host and
there is evidence that drug resistance may arise in schisto-
somes (2). The S. mansoni genome is 270Mb contained
in eight pairs of chromosomes (3). The present work
focuses on the computational genome analysis of this
parasitic species.
CONTENT OF THE CURRENT RELEASE
SchistoDB contains several diﬀerent S. mansoni data sets
and the results of diﬀerent computational analyses.
One highlight of the database is its integration to the
metabolic pathway prediction generated using the SRI
PathwayTools software (4). Pathway analysis allowed us
to select putative drug target candidates. The database
also contains all drugs available on KEGG drug database
(5), thus enabling us to indicate enzymes known to be
targeted in other organisms. Protein topology and cellular
location predictions are important tools for the selection
of vaccine candidates. We expect that SchistoDB will con-
tribute to eﬀorts towards the identiﬁcation of drug and
vaccine candidates in addition to a more comprehensive
analysis of genes.
Data
SchistoDB provides access to the latest draft genome
sequence and annotation of S. mansoni (6,7) (Puerto
Rico strain) obtained from the Wellcome Trust Sanger
Institute and the mitochondrial genome (8) (NMRI
strain). The current database version (Release 2.0) also
contains oligonucleotides (9) used in the Agilent 44K ele-
ment array widely used by the community and ESTs
mapped to the genome. The database provides the results
of computational analyses including open reading frames
(ORFs) >50 aa and protein feature predictions such as
signal peptides, transmembrane domains, hydrophobicity
plots and InterPro domains (10), Gene Ontology (11)
function predictions, EC Number assignment and
BLAST similarities to the NCBI non-redundant protein
database and Protein Data Bank database (12). We also
loaded the OrthoMCL (13) group of genes from S. mansoni
with orthologous genes from 86 other eukaryotic and
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KEGG (5) were loaded and their targets were associated
to S. mansoni genes that have matching EC numbers.
Users are able to visualize all data types in record pages
and by queries using the query interface (see Data-mining
tools section) (Table 1).
Database architecture
SchistoDB uses GUS 3.5 to systematically load data into
an underlying Oracle database. The open source database
schema (GUS—Genomics Uniﬁed Schema) uses con-
trolled vocabularies and ontologies to provide wide rela-
tions between the diﬀerent data types and analyses. Online
access to SchistoDB occurs via the GUS WDK (Web
Development Kit, www.gusdb.org/wdk) which facilitated
the creation of the website. The use of GUS signiﬁcantly
facilitates the data loading and analysis process, enabling
future and frequent release cycles. GUS and WDK have
been used for the development of other databases such as
PlasmoDB (14).
DATA-MINING TOOLS
SchistoDB currently provides approximately 30 diﬀerent
queries of the data and several tools for analyzing, retriev-
ing or viewing the data such as BLAST, Pathway Tools
and GMOD Genome Browser (15). Once the appropriate
selection of data types to display has been achieved, users
can integrate diﬀerent search results using the ‘Query
History’ page. Reﬁning the original query iteratively
until a narrow list of genes of interest is obtained, provid-
ing a manageable number of targets to validate, a time
consuming and expensive process. The data can also be
downloaded in ﬂat ﬁle format for further analysis.
GBrowse genome browser (www.gmod.org) is used in
SchistoDB to display gene models, EST alignments,
BLAST results, etc. GBrowse enables visualization of
the parasite genome and gene models, ORF identiﬁcation,
and facilitates downloading of data in various formats.
Diﬀerent tracks display each analyses or distinct data
sets within the genome browser.
Schistosoma mansoni metabolic pathways are available
through Pathway Tools web interface where several
queries provide access to pathways, reactions, enzymes,
compounds and other elements. The graphical overview
allows the user to visualize the complete set of pathways
and highlight speciﬁc reactions or perform organism com-
parison and expression analyses.
Mining for candidate drug and vaccine targets will ben-
eﬁt from many of the analyses available. SchistoDB inte-
grates diﬀerent datasets in a relational database that has
permitted us to apply a technique known as genomic ﬁl-
tering (16). Genomic ﬁltering allows the identiﬁcation of
gene products that might be of interest for drug targeting
based on several criteria e.g. absence of alternative path-
ways that consume or produce a given compound, pre-
sence or similarity to the host molecule to avoid toxicity,
EST evidence, cellular location, known drugs that target
the same gene product in other organisms or 3D models of
the protein. The presence of signal peptides and trans-
membrane domains will be important for the identiﬁca-
tion of vaccine candidates. EST evidence permits the
veriﬁcation if the putative target is expressed in the rele-
vant life cycle stages. The identiﬁcation of similar proteins
with structure information permits homology modeling of
S. mansoni proteins which will contribute to the design of
new chemicals and the identiﬁcation of exposed antigenic
peptides. The user could perform complex operations with
the results, such as use Boolean operators (AND, NOT,
OR) to search for proteins that, for example, have a signal
peptide, do not have transmembrane domains and are
expressed in the schistosomula life cycle stage according
to EST evidence, to identify secreted proteins.
Figure 1 shows an example where the combination of
the queries ‘Genes by PDB similarity’, ‘Genes by Drug
Evidence’ and ‘Genes by EST Evidence’ generates a
narrow list of 56 genes from a total of 13339. That
means, 56 genes have similar 3D structures in PDB data-
base, drugs known to target the same gene product in
other organims and also overlaping ESTs. Clicking on
any of the gene identiﬁers opens a page with information
on that gene. The search can be downloaded with user-
selectable features.
FUTURE DIRECTIONS
The current version contains only S. mansoni data, so the
expansion of the database will start with the integration of
data sets from other Schistosome species. We also expect
to load and integrate other data types such as SNPs,
microarray and SAGE. As new data are added, we will
include additional queries and tools to view these data.
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Table 1. Data types and sources that have been integrated into
SchistoDB and the number of genes that are impacted
Data type Data source Gene number
Protein coding genes Sanger 13339
Orthologs OrthoMCL 9516
GO—Gene Ontology Terms InterProScan 5667
EC—Ezyme Commission Numbers SchistoCyc 712
ESTs GenBank 9534
PDB—Protein Data Bank RSCB PDB 2713
D580 Nucleic Acids Research, 2009, Vol. 37, DatabaseissueFigure 1. Screenshots from SchistoDB displaying the ﬂow of a query. From the initial page users select from the various query choices for identifying
genes, contigs, ORFs or ESTs. From each query a results page is displayed. The results may be downloaded, combined or the query revised. The
query history page allows the user to manipulate previous results. Individual genes are displayed in the results page and it links to the gene page. In
the example, the gene for ribokinase is displayed. The gene results page includes: annotation, links to SchistoCyc and GeneDB, the gene model,
BLAST hits, EST clusters, microarray oligonucleotides, ORFs, EC, Gene Ontology, KEGG Drugs, Orthology, protein domains, the predicted
protein, mRNA and coding sequences.
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